- Home
- PAGS vs TARS Comparison
PAGS vs TARS Comparison
Compare PAGS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGS
- TARS
- Stock Information
- Founded
- PAGS 2006
- TARS 2016
- Country
- PAGS Brazil
- TARS United States
- Employees
- PAGS N/A
- TARS N/A
- Industry
- PAGS EDP Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- PAGS Technology
- TARS Health Care
- Exchange
- PAGS Nasdaq
- TARS Nasdaq
- Market Cap
- PAGS 2.2B
- TARS 2.1B
- IPO Year
- PAGS N/A
- TARS 2020
- Fundamental
- Price
- PAGS $6.72
- TARS $46.52
- Analyst Decision
- PAGS Buy
- TARS Strong Buy
- Analyst Count
- PAGS 12
- TARS 5
- Target Price
- PAGS $13.42
- TARS $54.20
- AVG Volume (30 Days)
- PAGS 4.3M
- TARS 735.2K
- Earning Date
- PAGS 02-26-2025
- TARS 02-25-2025
- Dividend Yield
- PAGS N/A
- TARS N/A
- EPS Growth
- PAGS 29.62
- TARS N/A
- EPS
- PAGS 1.15
- TARS N/A
- Revenue
- PAGS $3,233,044,341.00
- TARS $129,621,000.00
- Revenue This Year
- PAGS $20.90
- TARS $917.88
- Revenue Next Year
- PAGS $11.19
- TARS $78.70
- P/E Ratio
- PAGS $5.85
- TARS N/A
- Revenue Growth
- PAGS 14.87
- TARS 801.96
- 52 Week Low
- PAGS $6.11
- TARS $20.08
- 52 Week High
- PAGS $14.98
- TARS $57.14
- Technical
- Relative Strength Index (RSI)
- PAGS 50.11
- TARS 37.06
- Support Level
- PAGS $6.50
- TARS $43.61
- Resistance Level
- PAGS $6.95
- TARS $57.00
- Average True Range (ATR)
- PAGS 0.24
- TARS 2.65
- MACD
- PAGS 0.10
- TARS -1.27
- Stochastic Oscillator
- PAGS 72.62
- TARS 21.51
About PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused primarily on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.